Xyntha Kit
Product Images NDC 58394-014
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 46 technical images submitted to the FDA as part of the official labeling for Xyntha (NDC 58394-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Xyntha 02)
Figure (Xyntha 03)
Figure (Xyntha 04)
Figure (Xyntha 05)
Figure (Xyntha 06)
Figure (Xyntha 07)
Figure (Xyntha 08)
Figure (Xyntha 09)
Figure (Xyntha 10)
Figure (Xyntha 11)
Figure (Xyntha 12)
Figure (Xyntha 13)
Figure (Xyntha 14)
Figure (Xyntha 15)
Figure (Xyntha 16)
Figure (Xyntha 17)
Figure (Xyntha 18)
Figure (Xyntha 19)
Figure (Xyntha 20)
Figure (Xyntha 21)
Figure (Xyntha 22)
Figure (Xyntha 23)
Figure (Xyntha 24)
Figure (Xyntha 25)
Figure (Xyntha 26)
Figure (Xyntha 27)
Figure (Xyntha 28)
Figure (Xyntha 29)
Figure (Xyntha 30)
Figure (Xyntha 31)
Figure (Xyntha 32)
Figure (Xyntha 33)
Figure (Xyntha 34)
Figure (Xyntha 35)
Logo (Xyntha 36)
Principal Display Panel (4ML VIAL LABEL)
Principal Display Panel (250 IU Label)
This appears to be a description of a disposable syringe used for drug diluent with Xyntha® antihemophilic factor. The syringe contains 0.9% sodium chloride diluent solution and is made by Wyeth Pharmaceuticals LLC. The product is sterile and non-pyrogenic, without any preservatives. However, there isn't any information on the manufacturing date, LOT or EXP numbers.*
Principal Display Panel (Kit Carton)
Xyntha® PAA134628 is a medication used for Factor VII replacement in individuals with antihemophilic factor deficiency. It is produced by recombinant technology and has a concentration of 250 IU. The medication is stored in a refrigerator between 2 to 8°C (36° to 46°F). Further dosage information and packaging details are available on the packaging label.*
Principal Display Panel (500 IU)
Principal Display Panel (Kit Carton)
This is a description of a medication called "xyntha® IR," which is essentially a recombinant antihemophilic factor used to treat patients with hemophilia A. The medication is stored in a refrigerator at a temperature range of 2°C-8°C. The text also contains a reference to "Factor VIll : S PAA134620," which may be a code or identifier related to the medication.*
Principal Display Panel (1000 IU)
Principal Display Panel (Kit Carton)
Principal Display Panel (2000 IU)
This is a product description for Xyntha, an antihemophilic factor manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. It is used for factor VII replacement therapy and can only be administered intravenously. Each package contains a single-use vial with a prefilled diluent syringe of 1000 IU range, and it is available at room temperature. The text includes some errors and non-English characters.*
Principal Display Panel (Kit Carton)
Xyntha 46
This is a product description of a single-use vial containing 4 mL of antihemophilic factor medicine for intravenous administration. The medicine is manufactured by Wyeth Pharmaceuticals, LLC, which is a subsidiary of Pfizer Inc. The product is for therapy only and is used for factor VII replacement for hemophiliacs. The product has a GTIN number that starts with 003583 and can be stored in room temperature. There is also information regarding storage, handling, usage, and expiration date, which must be checked before use. Some information on the product is unavailable due to errors.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.